Isobutylene polymer active compound release systems

Claim 2

In a therapeutic system including a covering layer which is essentially impermeable to an active compound, an active compound reservoir layer and a protective layer which can be pulled off and which is essentially impermeable to the active compound, the improvement comprising the reservoir layer containing about 1-30% of active compound, about 30-60% by weight of a polymer selected from the group consisting of polyisobutylenes, copolymers of polyisobutylenes and mixtures thereof, 30-60% by weight of an entraining agent selected from the group consisting of oils, fatty acid esters, triglycerides, alcohols, fatty acids and mixtures thereof and 2-40% by weight of a resin selected from the group consisting of rosin, dehydrogenated rosin, glycerol esters of dehydrogenated rosin, glycerol esters of rosin gum, hydrogenated rosin, glycerol esters of hydrogenated rosin, pentaerythritol esters of hydrogenated rosin, methyl esters of hydrogenated rosin, polymerized rosin, glycerol esters of polymerized rosin, terpene resins, coumarone/indene resins, hydrogenated petroleum resins, rosin modified by maleic anhydride, C 5 -petroleum resins, half-esters of styrene/maleic acid copolymers, and mixtures thereof, in addition to the active compound.

Claim 3

A therapeutic system comprising a plaster for administration of an active compound through the skin, and comprising a covering layer, a reservoir layer which contains the active compound and also contains a polymer, an entraining agent selected from the group consisting of oils, fatty acid esters, triglycerides, alcohols, fatty acids and mixtures thereof, a resin, said resin selected from the group consisting of rosin, dehydrogenated rosin, glycerol esters of dehydrogenated rosin, glycerol esters of rosin gum, hydrogenated rosin, glycerol esters of hydrogenated rosin, pentaerythritol esters of hydrogenated rosin, methyl esters of hydrogenated rosin, polymerized rosin, glycerol esters of polymerized rosin, terpene resins, coumarone/indene resins, hydrogenated petroleum resins, rosin modified by maleic anhydride, C 5 -petroleum resins and half-esters of styrene/maleic acid copolymers, and mixtures thereof, and a protective layer which can be pulled off, wherein the polymer of the reservoir layer containing active compound is selected from the group consisting of polyisobutylene and a copolymer of isobutylene with 1-5 mol% of conjugated diene having a molecular weight distribution m w /M n of 1.5-3.5 and a viscosity average molecular weight of 30,000 to 4,000,000, the reservoir containing 2-30% by weight of an antiphlogistic as active compound.

Claim 4

A therapeutic system comprising a plaster for administration of an active compound through the skin, and comprising a covering layer, a reservoir layer which contains the active compound and also contains a polymer, an entraining agent selected from the group consisting of oils, fatty acid esters, triglycerides, alcohols, fatty acids and mixtures thereof, a resin, said resin selected from the group consisting of rosin, dehydrogenated rosin, glycerol esters of dehydrogenated rosin, glycerol esters of rosin gum, hydrogenated rosin, glycerol esters of hydrogenated rosin, pentaerythritol esters of hydrogenated rosin, methyl esters of hydrogenated rosin, polymerized rosin, glycerol esters of polymerized rosin, terpene resins, coumarone/indene resins, hydrogenated petroleum resins, rosin modified by maleic anhydride, C 5 -petroleum resins and half-esters of styrene/maleic acid copolymers, and mixtures thereof, and a protective layer which can be pulled off, wherein the polymer of the reservoir layer containing active compound is selected from the group consisting of polyisobutylene and a copolymer of isobutylene with 1-5 mol% of conjugated diene having a molecular weight distribution m w /M n of 1.5-3.5 and a viscosity average molecular weight of 30,000 to 4,000,000, the reservoir containing 2-30% by weight of an antiphlogistic as active compound.

Claim 5

A therapeutic system according to claim 1, wherein the polymer comprises polyisobutylene with a viscosity average molecular weight of 50,000-1,000,000 g/mol.

Claim 6

A therapeutic system according to claim 1, wherein the polymer comprises a copolymer of isobutylene with 1-5 mol % of conjugated diolefin.

Claim 7

A therapeutic system according to claim 1, wherein the entraining agent comprises at least one of paraffin oil and liquid polybutadiene oil.

Claim 8

A therapeutic system according to claim 1, wherein the active compound is selected from the group consisting of antiphlogistics of the formula ##STR32## and esters and amides thereof, in which R 1 -R 5 each independently is hydrogen, halogen, lower alkyl or substituted alkyl, X is N or CH, Y is hydrogen, a metal ion, alkyl or substituted alkyl, R is hydrogen, lower alkyl or substituted alkyl, Ar is aryl, heteroaryl, substituted aryl or substituted heteroaryl, n and m each is an integer and together total zero, 1 or 2, and p is zero or 1, with the proviso that Ar is not aryl or heteroaryl if n, m and p each is zero.

Claim 9

A plaster according to claim 2, wherein the entraining agent comprises isopropyl myristate.

Claim 10

A system according to claim 1, wherein the active compound is etofenamat.

Claim 11

A system according to claim 1, wherein the active compound is ketoprofen.

Claim 12

A system according to claim 1, wherein the active compound is acematacin.

Claim 13

A system according to claim 1, wherein the active compound is indoprofen.

Claim 14

A system according to claim 1, wherein the active compound is indometacin.